CELU241220C7500
- 0.40
- 0.000.00%
Celularity Newsroom
Celularity's Strategic Partner Announces Groundbreaking For Stem Cell & Regenerative Medicine Center In Asia Pacific
Express News | Celularity Shares Are Trading Higher. The Nasdaq Listing Qualifications Hearings Panel Has Cancelled the Previously Scheduled Hearing Regarding the Company's Non-compliance
Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter
Sector Update: Health Care Stocks Rise Late Afternoon
Celularity CELU Increased Sales Guidance; Ensysce ENSC NASDAQ Extension
Top Midday Gainers
Express News | Celularity Shares Halted To The Upside; Stock Now Up 161.38%
10-Q: Q2 2024 Earnings Report
12 Health Care Stocks Moving In Thursday's Intraday Session
Celularity Raises FY24 Revenue View to $54M-$60M From $50M-$56M
Express News | Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million
Press Release: Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million
Celularity to Submit 510(k) Notification for Tendon Wrap in Early 2025
Express News | Celularity : Intend to File Form 10-Q for Q2 2024 Within Coming Weeks
Express News | Celularity Provides Corporate Update
Sector Update: Health Care Stocks Fall Late Afternoon
Celularity Inc. Receives Notice From Nasdaq; Confirms Intention to File an Appeal
10-Q: Q1 2024 Earnings Report
Press Release: Celularity Expands Advanced Biomaterial Product Commercial Portfolio With Acquisition of Rebound(TM) Product From Sequence LifeScience, Inc.
Express News | Celularity Expands Advanced Biomaterial Product Commercial Portfolio With Acquisition of Rebound™ Product From Sequence Lifescience, Inc.